Penelitian ini merupakan uji klinik fase II dengan tujuan untuk mengetahui daya guna (efektivitas) dan keamanan kontrasepsi Implanon@. Penelitian direncanalcan berlangsung 2 tahun dengan kemungkilran diperpanjang menjadi 3 atau 4 tahun. Dari 200 subyek yang dipasang Implanon@, hanya 150 yang melanjutkan pemakaian pada tahwt ketiga dan hanya 124 yang melanjutkan pemakaian pada tahun keempat. TÏdak ditemul<an kehamilan selamn pemakaian Implanon@ (658, 4 tahun wanita). Satu subyek menghentikan pemal<aian l<arena amenorea (0,57o). Tidak ada penghentian pem.alcaian yang disebabkan oleh gangguan perdarahan. Pada umurnnya keluhan subyektif yang dialnmi bersifut rtngan (sakit kepala). Tidak ditemukan kelainan pada pemerilcsaanfisik, ginekologi dan Pap smear Tiiak ditemulcan peninglatan bermalaa teknnan darah. Dilapatkan kenaikan berat badan sebesar 2-7Vo setel^ah I tahun pemakaian. Disimpullcan bahwa Implanon@ merupakan kontrasepsi yang efektif dengan efek samping normal.
96 subjects completed. There was no pregnancy occurred in four years of use, a total exposure of 658.4 woman-years. One subject discontinued due to amenorrhoea (0.5%o). None ofthe subjects discontinuedfor bleeding irregularities, A total of4 subjects (2.0Vo) reported at least one side-effect. No serious side-effects were reported. Three (1.5Vo) subjects discontinued due to siàe-effects as primary reason.
Side-effects that were considered drug-related were headache and dyspnoea (reported by two and one subjects, respectively). Six subjects once had a clinically significant low value for haemoglobin and for one subject this occurred twice during treatment. Except for " headache" and " dyspnoea" (reported tvvice and once, respectively), no clinically reLevant shifts from normal to abnormal were reported with respect to physical examinations and gynecological evaluations. At implant removal, Pap smear class I was reported for all subjects but one (Pap II). No clinically signfficant values of systolic and diastolic blood pressure were observed. An effect on body mass index was indicated by a slight mean increase (about from the month 12 assessment onwards: an increase of 10Vo or more at any time-point was reported by 41 subjects (20.5Vo). It is concluded thnt the single implant contraceptive containing 3- 
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PmfiIe of the subjecb
The prof,rle of the subjects are described in 
Acceptability
The continuation rates are shown in Table 4 
Reasons for discontinuation
In the year-l there were 3 subjects (1.580) discontinued the method use being one subject due to planning pregnancy and one subject due to personal reason.
InThe year-2 there were four more subjects discontin- The number of subjects who completed the study or discontinued method is shown in Table 3 However there was a slight mean increase in year-3 and year-4 being 1.0 and 1.0 mmHg for systolic and 1.3 and 0.5 for diastolic. There was no subject discontinued due to blood pressure changes.
Vaginat bleeding analysis
Completed vaginal bleeding record cards were obtained from the subjects throughout the study. The vaginal bleeding patterns as determined by analysis of these records will be described in other paper. It is concluded that Implanon@ is a highly effective contraceptive method with minimal side-effects.
